HAMBURG, Germany and OXFORD, UK, July 14, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC), a leading provider in the discovery and development of novel small molecule drugs, today announced that it has entered into a research agreement with Cubist Pharmaceuticals, Inc. (Nasdaq:CBST), a leading acute care biopharmaceutical company located in Lexington, Mass., USA.
